News
The FDA has accepted for review the second resubmitted NDA for reproxalap for the treatment of the signs and symptoms of dry eye disease.
3d
InvestorsHub on MSNViatris Shares Dip After Blepharitis Treatment Fails to Hit Main Study Goal
Viatris Inc. (NASDAQ:VTRS) saw its stock drop 3.6% following news that its late-stage trial for MR-139, a potential treatment ...
Viatris's said on Friday that the trial of an ointment for people with blepharitis didn't meet its primary endpoint.
Aldeyra Therapeutics (ALDX) stock in focus as the FDA accepts its resubmitted marketing application for lead drug reproxalap ...
Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Eye (Lond). 2007;21 (7):968-75. 15 Taddio A, Cimaz R, Caputo R, de Libero C, Di Grande L, ...
I have my mother to blame (and thank) for that. Early on, my mother instilled in me the importance of establishing a beauty regimen before I could properly pronounce the word “moisturize.” Aquaphor ...
Aim To report a 10-year follow-up of patients suffering from severe dry eye syndrome (DES) initially treated with topical ciclosporin A (tCSA) for 6 months. Methods The charts of 26 patients with ...
“Having a healthcare provider treat your baby’s eyes with erythromycin ointment after birth is a scientifically-proven, simple, harmless, and cost-effective way to prevent infant blindness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results